Compositions, packaged pharmaceuticals, and methods of treatment by thesensitization of resistant tumors are provided.The compositions comprise posaconazole and a chemotherapeutic agent. Tumorcells in mammalian subjects treated with posaconazoleare sensitized to the effects of the chemotherapeutic agent, thus increasingthe therapeutic index of the agent and reducing toxicity tothe subject.